Cargando…

Su325 HEPATIC STEATOSIS MAY LEAD TO WORSE OUTCOMES IN PATIENTS WITH LIVER INJURY AND COVID-19

Detalles Bibliográficos
Autores principales:	Shaikh, Danial H., Sun, Haozhe, Patel, Harish, Shin, Dongmin, Baiomi, Ahmed, Mehershahi, Shehriyar, Ravi, Madhavi, Makker, Jasbir, Balar, Bhavna, Nayudu, Suresh Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2021
Materias:	AASLD Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108228/ http://dx.doi.org/10.1016/S0016-5085(21)02761-X

Ejemplares similares

Patients with Clostridium difficile infection and prior appendectomy may be prone to worse outcomes
por: Shaikh, Danial Haris, et al.
Publicado: (2021)

Characteristics of Patients with Post-Colonoscopy Unplanned Hospital Visit: A Retrospective Single-Center Observational Study
por: Makker, Jasbir, et al.
Publicado: (2021)

Thalidomide for the treatment of angiodysplasia‐related recurrent gastrointestinal hemorrhage: Is low dose a safe and viable option?
por: Patel, Harish, et al.
Publicado: (2019)

Paclitaxel-Induced Bowel Perforation: A Rare Cause of Acute Abdomen
por: Shaikh, Danial Haris, et al.
Publicado: (2020)

Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study
por: Makker, Jasbir, et al.
Publicado: (2021)

Metastasis From Gastric Signet Ring Cell Adenocarcinoma Presenting as a Rectosigmoid Stricture: A Rare Case
por: Mehershahi, Shehriyar, et al.
Publicado: (2020)

Nonsteroidal Anti-Inflammatory Drugs Impact on the Outcomes of Hospitalized Patients with Clostridium difficile Infection
por: Patel, Harish, et al.
Publicado: (2019)

Recent Anti-platelet Therapy Revealing Underlying Undiagnosed Gastrointestinal Stromal Tumor in Otherwise Healthy Patient
por: Mehershahi, Shehriyar, et al.
Publicado: (2020)

The Incidence and Mortality Impact of Gastrointestinal Bleeding in Hospitalized COVID-19 Patients
por: Makker, Jasbir, et al.
Publicado: (2021)

Su322 SEVERE CHOLESTATIC HEPATITIS SECONDARY TO SARS-COV-2
por: Lindholm, Christopher R., et al.
Publicado: (2021)

Mo1330: THE IMPACT OF COVID-19 ON ALCOHOLIC LIVER DISEASES IN A PREDOMINANTLY AFRICAN AMERICAN AND HISPANIC COMMUNITY
por: Sun, Haozhe, et al.
Publicado: (2022)

Su326 IS TRANSAMINITIS AN INDEPENDENT RISK FACTOR FOR ALL-CAUSE MORTALITY IN COVID-19?
por: Mughal, Mohsin, et al.
Publicado: (2021)

Su327 DIAGNOSIS AND CHARACTERISTICS OF IMMUNE CHECKPOINT INHIBITOR-MEDIATED CHOLANGIOPATHY: A CASE SERIES
por: Eyada, Mostafa, et al.
Publicado: (2021)

Su324 THE IMPACT OF THE COVID-19 PANDEMIC ON LIVER BIOMARKERS AND QUALITY OF LIFE IN PATIENTS WITH NAFLD
por: Clarke, Lindsay M., et al.
Publicado: (2021)

Su319 KEY PRO-INFLAMMATORY/INJURY FEATURES OF COVID-19 PATIENTS WITH ALCOHOL USE
por: Rios, Cristian D., et al.
Publicado: (2021)

Su1373: UTILIZATION OF DRUG OVERDOSE DONORS FOR LIVER TRANSPLANTATION DURING COVID-19 PANDEMIC
por: Lymberopoulos, Peter, et al.
Publicado: (2022)

Acute Cholecystitis, A Rare Complication Following Routine Colonoscopy: Case Series and Literature Review
por: Shaikh, Danial H, et al.
Publicado: (2020)

Su323 THE PATTERNS OF LIVER INJURY IN COVID-19 POSITIVE PREGNANT FEMALES: A CASE SERIES
por: Raju, Sneha, et al.
Publicado: (2021)

Su317 CORONAVIRUS DISEASE 2019 AND LIVER INJURY: A RETROSPECTIVE ANALYSIS OF HOSPITALIZED PATIENTS IN NEW YORK CITY
por: Bender, Joshua M., et al.
Publicado: (2021)

Su321 DEGREE AND PATTERN OF ELEVATED HEPATOBILIARY ENZYMES ARE PROGNOSTIC OF SEVERE CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS
por: Wagner, Jason, et al.
Publicado: (2021)

Su318 PATTERNS OF LIVER TRANSPLANTATION EVALUATIONS FOR HOSPITALIZED ADULTS WITH ACUTE ALCOHOLIC HEPATITIS DURING COVID-19: A SINGLE CENTER STUDY
por: Bangaru, Saroja, et al.
Publicado: (2021)

Su320 A RETROSPECTIVE ANALYSIS OF OUTCOMES AMONGST COVID-19 PATIENTS WITH ACUTE HEPATITIS RECEIVING N-ACETYLCYSTEINE THERAPY IN A SAFETY NET HOSPITAL
por: Pellegrini, James R., et al.
Publicado: (2021)

Su316 INCREASED DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN HOSPITALIZED PATIENTS WITH ALCOHOL RELATED HEPATITIS AFTER THE COVID-19 OUTBREAK: A GLOBAL MULTI-CENTER PROPENSITY MATCHED ANALYSIS.
por: Perisetti, Abhilash, et al.
Publicado: (2021)

Apixaban Causing Hepatic Cystic Bleeding: A Rare but a Life-Threatening Complication
por: Shehi, Elona, et al.
Publicado: (2021)

Enoxaparin-Induced Liver Injury
por: Mehershahi, Shehriyar, et al.
Publicado: (2020)

McKittrick-Wheelock Syndrome: A Rare Cause of Chronic Diarrhea
por: Jyala, Abhilasha, et al.
Publicado: (2021)

Colitis Induced by Colon-Cleansing Agent
por: Mehershahi, Shehriyar, et al.
Publicado: (2021)

Abdominal Ascites of Unknown Origin: Diagnostic Accuracy of Adenosine Deaminase for Tuberculous Peritonitis
por: Mehershahi, Shehriyar, et al.
Publicado: (2021)

Non-Steroidal Anti-Inflammatory Drugs: A Rare Cause of Colonic Mass
por: Baiomi, Ahmed, et al.
Publicado: (2021)

A juvenile polyp on colonoscopy, is it premalignant?
por: Kumar, Kishore, et al.
Publicado: (2019)

Clinical relevance of endoscopically identified extrinsic compression of the oesophagus and stomach
por: Kumar, Kishore, et al.
Publicado: (2019)

310 Ribavirin coupled to hemoglobin protects against viral hepatitis induced by the corona virus MHV-3 in mice
por: Levy, Gary A., et al.
Publicado: (2003)

437 A TAILORED PROGRAM FOR SCREENING, IMPROVED ACCESS TO CARE, AND PRIORITIZATION OF TREATMENT FOR PWUD WITH CHRONIC HCV INFECTION.
por: Mangia, Alessandra, et al.
Publicado: (2021)

13 CHEMOPREVENTIVE EFFECT OF STATIN ON HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH CIRRHOSIS
por: Al-Yaman, Wael A., et al.
Publicado: (2021)

7 A RETROSPECTIVE ANALYSIS OF COVID-19 INFECTED PATIENTS WITH ACUTE LIVER FAILURE IN A SAFETY NET HOSPITAL
por: Pellegrini, James R., et al.
Publicado: (2021)

8 PREDICTORS OF OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
por: Sandhu, Sunny, et al.
Publicado: (2021)

12 MULTIFOCAL INTRAHEPATIC CHOLANGIOCARCINOMA: IMMUNOGENOMIC AND EPIGENOMIC HETEROGENEITIES INFLUENCE THE RESPONSES TO TARGETED THERAPY AND IMMUNOTHERAPY
por: Chen, Shu-Ling, et al.
Publicado: (2021)

9 ELEVATED LIVER ENZYMES PORTENDS A HIGHER RATE OF COMPLICATIONS AND DEATH IN ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)
por: Currier, Emily E., et al.
Publicado: (2021)

6 CIRRHOSIS IS ASSOCIATED WITH SIGNIFICANTLY WORSENED CLINICAL OUTCOMES OF COVID-19 INFECTION IN A RETROSPECTIVE ANALYSIS OF 23,474 PATIENTS ACROSS 143 HOSPITALS
por: Hwang, Andrew W., et al.
Publicado: (2021)

435 INCIDENCE AND MORTALITY OF COVID-19 IN POST-LIVER TRANSPLANT PATIENTS IN A LARGE INTEGRATED HEALTHCARE SYSTEM
por: Tien, Andy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mjfaqnv3e7med02efnpnig6gom